Artivion | CRY - Koszty Sprzedaży





Koszty Sprzedaży Zmiana Data
Abbott USD 6.47B 525M 2026-09
Accuray USD 116.17M 14.63M 2024-12
AngioDynamics USD 37.29M 786K 2025-09
Artivion USD 42.85M 3.86M 2025-12
AtriCure USD 35.1M 125K 2026-09
Baxter International USD 1.98B 54M 2026-09
Becton, Dickinson and Co. USD 2.58B 87M 2026-09
Boston Scientific USD 1.96B 93M 2026-09
Edwards Lifesciences USD 369.2M 23.2M 2026-09
Inogen USD 39.59M 1.27M 2024-09
Integra LifeSciences USD 186.73M 2.13M 2026-09
J&J USD 8.08B 80M 2026-09
Mesa Laboratories USD 21.92M 1.78M 2024-09
Orthofix International USD 66.63M 6.4M 2025-12
Pfizer USD 4.03B 64M 2026-09
ResMed USD 612.93M 61.26M 2026-06
Stryker USD 2.26B 106M 2026-06
Tandem Diabetes Care USD 123.27M 13.49M 2026-09
Teleflex USD 199M 39.63M 2026-09
Terumo JPY 133.27B 18.03B 2026-06
Trinity Biotech USD 7M 171K 2026-03